Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C: current approaches in pediatrics.

Carolina Rumbo1

  • 1Pediatric Liver/Liver Transplant Program, Division of Pediatric Hepatology and Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, NY 10029, USA. carolina.rumbo@msnyuhealth.org

Pediatric Transplantation
|September 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric liver transplantation for metabolic diseases: a single-center experience.

World journal of pediatrics : WJP·2026
Same author

Expanding Pediatric Liver Transplant Options: On-pump Split Reduction With Normothermic Machine Perfusion.

Transplantation·2026
Same author

Liver Transplantation for Diffuse Infantile Hepatic Hemangioma and Acute Liver Failure: A Case Report.

Pediatric transplantation·2026
Same author

Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study.

Intestinal Failure (New York, N.Y.)·2026
Same author

Real-world effectiveness and safety of teduglutide in adult and pediatric patients with short bowel syndrome in Argentina.

World journal of gastrointestinal pharmacology and therapeutics·2025
Same author

Using SARS-CoV-2-Positive Donors Under 1 Year of Age: A Case Series of Successful Combined Liver-Pancreas and Isolated Liver Pediatric Transplantation.

Pediatric transplantation·2025

Chronic hepatitis C virus (HCV) infection is a major cause of liver disease in adults. This overview focuses on the distinct aspects of chronic HCV in children, including acquisition, progression, and treatment.

Area of Science:

  • Hepatology
  • Pediatric Infectious Diseases
  • Virology

Background:

  • Chronic hepatitis C virus (HCV) infection is a significant global health concern, primarily affecting adults.
  • HCV is a leading cause of liver disease and the most common indication for liver transplantation in the USA.
  • Hepatitis C in children is less common, with limited data on its clinical presentation and management.

Purpose of the Study:

  • To provide a comprehensive overview of chronic hepatitis C in pediatric populations.
  • To highlight the differences in HCV infection between children and adults.
  • To summarize current knowledge on the epidemiology, clinical course, and treatment of pediatric HCV.

Main Methods:

  • Literature review of studies on chronic hepatitis C in children.

Related Experiment Videos

  • Analysis of epidemiological data and clinical case reports.
  • Synthesis of information regarding viral acquisition, disease progression, and therapeutic options in pediatric patients.

    • Main Results:

    • Hepatitis C infection in children differs from adults in terms of acquisition routes and natural history.
    • Pediatric HCV may present unique challenges in diagnosis and management.
    • Specific treatment strategies and outcomes in children require further investigation.

    Conclusions:

    • Chronic hepatitis C in children represents a distinct clinical entity compared to adults.
    • Further research is needed to fully understand the long-term implications and optimize treatment for pediatric HCV.
    • Raising awareness and improving diagnostic and therapeutic approaches for childhood hepatitis C are crucial.